BH-4601

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameBH-4601
Drug Alias NameBH-4601
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > XYD-295 payload
Mechanisms of ActionAnti-Programmed death-ligand 1Anti-CD276DNA topoisomerase I inhibitors
TargetsProgrammed death-ligand 1CD276 antigenDNA topoisomerase I
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Hanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Hanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A